Welcome to our dedicated page for Novanta SEC filings (Ticker: NOVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Novanta Inc. filings document the company's operating results, governance matters and capital structure as an operating technology supplier to medical and advanced technology equipment manufacturers. Form 8-K reports furnish earnings releases and financial guidance updates, report board and committee changes, and disclose authorizations for common-share repurchases.
The company's filings also include capital-markets disclosures for Novanta's 6.50% tangible equity units, including underwriting arrangements, unit issuance and related registration-statement references. The definitive proxy statement covers shareholder voting matters, board governance, executive compensation, equity awards and pay-versus-performance information for the company's annual meeting process.
Novanta Inc. Chief Executive Officer and director Matthijs Glastra reported an insider sale of common stock. On January 9, 2026, a total of 6,177 shares of Novanta common stock were sold at $130 per share, coded as an open market sale.
The filing notes that these sales were carried out under a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person’s spouse is a trustee. After this transaction, Glastra beneficially owned 78,867 shares directly and 54,382 shares indirectly through the Matthijs Glastra 2021 Irrevocable Trust, indicating he continues to hold a significant equity position in Novanta.
Novanta Inc. Chief Executive Officer and director Matthijs Glastra reported a small insider sale of company stock. On January 8, 2026, he sold 323 shares of Novanta Inc. common stock at a weighted-average price of $130.14 per share, coded as an open market sale. The transaction was carried out under a pre-established Rule 10b5-1 trading plan adopted on September 11, 2025, which is designed to allow automated trading according to preset instructions.
Following this sale, Glastra beneficially owns 85,044 shares directly and an additional 54,382 shares indirectly through the Matthijs Glastra 2021 Irrevocable Trust, for which his spouse serves as trustee.
A holder of Novanta, Inc. common stock filed a notice to sell 6,177 shares through Merrill Private Wealth Management on the NASDAQ market. The filing reports an aggregate market value of 803,010 for these shares, compared with 35,775,123 common shares outstanding. The seller acquired the 6,177 shares as restricted stock units from Novanta on 01/02/2024 as equity compensation. The notice also discloses that the same person sold 323 common shares for gross proceeds of 41,990 on 01/08/2026.
A holder has filed a notice of proposed sale under Rule 144 for 323 shares of Novanta, Inc. common stock. The shares are planned to be sold on or about 01/08/2026 on the NASDAQ market through Merrill Private Wealth Management. The filing notes that 35,775,123 shares of Novanta common stock were outstanding. These 323 shares were originally acquired on 01/02/2024 as restricted stock units from Novanta, Inc. as a form of equity compensation, with payment also dated 01/02/2024 and described as equity compensation.
Novanta Inc. director Wilson Frank Anders reported equity award activity on January 2, 2026. He settled 1,325 Restricted Stock Units (RSUs), which were each the economic equivalent of one Novanta common share, into 1,325 shares of common stock, bringing his directly held common stock to 3,947 shares following the transaction.
On the same date, he received a new grant of 1,799 RSUs, each representing the right to receive one Novanta common share on the first anniversary of the grant date (or the next business day). These RSUs were fully vested and non‑forfeitable on the grant date, leaving him with 1,799 RSUs beneficially owned after the reported transactions.
Novanta Inc. director Mauricio Maxine Lum reported equity compensation activity involving restricted stock units (RSUs) and common shares. On January 2, 2026, 1,325 RSUs, each equal to one Novanta common share, were settled into 1,325 shares of common stock at a reported price of $0 per share, bringing Lum’s directly held common stock to 4,548 shares.
On the same date, Lum received a new award of 1,799 RSUs. Each of these RSUs represents the right to receive one Novanta common share on the first anniversary of the grant date (or the next business day). The filing notes that these RSUs were fully vested and non-forfeitable on the grant date and that Lum now directly holds 1,799 RSUs after the reported transactions.
Novanta Inc. director Darlene J. S. Solomon reported restricted stock unit activity and related common share ownership changes. On January 2, 2026, 1,325 restricted stock units were settled into 1,325 Novanta common shares at a price of $0 per share, leaving her with 3,541 common shares held directly. The filing also reports a grant of 1,799 restricted stock units on the same date, each representing the right to receive one Novanta common share on the first anniversary of the grant date. These newly granted units were fully vested and non-forfeitable on the grant date, and she holds 1,799 restricted stock units directly after the transactions.
Novanta Inc. director Thomas N. Secor reported equity-related transactions in company stock. On January 2, 2026, 1,325 Restricted Stock Units (RSUs) were settled into 1,325 shares of Novanta common stock at a reported price of $0.00 per share, leaving him with 1,325 common shares held directly. Each RSU was the economic equivalent of one common share.
On the same date, Secor was also awarded 1,799 new RSUs at a price of $0.00, with each unit representing the right to receive one Novanta common share on the first anniversary of the grant date (or the next business day). The filing notes that these RSUs were fully vested and non‑forfeitable on the grant date.
Novanta Inc. director Robert Matthew Johnson reported routine equity compensation activity. On January 2, 2026, 1,325 Restricted Stock Units (RSUs), each equivalent to one Novanta common share, were settled into 1,325 shares of common stock. After this settlement, he directly held 2,143 shares of common stock.
On the same date, Johnson was granted 1,799 new RSUs, each representing the right to receive one Novanta common share on the first anniversary of the grant date (or the next business day). These RSUs were fully vested and non‑forfeitable at grant, and he held 1,799 derivative securities (RSUs) directly following the grant.
Novanta Inc. director Lonny J. Carpenter reported equity awards and a share settlement. On January 2, 2026, he received 1,799 Restricted Stock Units (RSUs), each representing the right to receive one Novanta common share, with no cash paid per unit. On the same date, 1,325 previously held RSUs were settled into 1,325 shares of common stock, reflecting that each RSU was the economic equivalent of one common share and had become fully vested and non‑forfeitable. Following these transactions, Carpenter directly owned 5,848 shares of common stock and held 1,799 RSUs outstanding.